| 25-902 |
Novartis Pharmaceuticals Corporation v. Robert F. Kennedy, Secretary of Health and Human Services, et al. |
Third Circuit |
2026-02-02 |
Pending |
|
anti-injunction-act civil-penalty drug-price-negotiation excessive-fines-clause fifth-amendment first-amendment |
The Drug Price Negotiation Program (Program) threatens enterprise-destroying fines unless a drug manufacturer both provides its products at government… |
| 25-348 |
AstraZeneca Pharmaceuticals LP, et al. v. Robert F. Kennedy, Secretary of Health and Human Services, et al. |
Third Circuit |
2025-09-24 |
Pending |
|
drug-price-negotiation due-process government-pricing inflation-reduction-act medicare-transactions pharmaceutical-manufacturers |
Whether the IRA implicates an interest of pharmaceutical manufacturers that is protected by the Due Process Clause. |
| 25A115 |
AstraZeneca Pharmaceuticals LP, et al. v. Robert F. Kennedy, Secretary of Health and Human Services, et al. |
Third Circuit |
2025-07-28 |
Presumed Complete |
|
drug-price-negotiation due-process inflation-reduction-act medicare patent-rights pharmaceutical-regulation |
Whether the government's mandatory drug price negotiation program under the Inflation Reduction Act violates pharmaceutical manufacturers' due process… |